Hepatitis C virus and the threshold of natural killer cell inhibition

Hepatology

Volumn 41, Issue 3, 2005, Pages 675-677

  Ahlenstiel, Golo ^a   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AFRICAN AMERICAN; CAUCASIAN; CELL INTERACTION; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; VIRUS IMMUNITY;

HEPACIVIRUS; HEPATITIS C; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC;

EID: 14244265799     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20622     Document Type: Note

References (21)

1. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
2. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990;172:1589-1598.
3. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753-763.
4. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997;7:739-751.
5. Carrington M, Norman P. The KIR Gene Cluster. 1st ed: NCBI, NLM, U.S. Government, 2003: 48. Available at: http://www.ncbi.nlm.nih.gov/books/.
6. Watzl C, Stebbins CC, Long EO. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J Immunol 2000;165:3545-3548.
7. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004;305:872-874.
8. Fanning LJ, Kenny-Walsh E, Shanahan F. Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. Hum Immunol 2004;65:745-751.
9. Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001;184:16-21.
10. Yee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun 2004;5:237-245.
11. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998;161:571-577.
12. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, et al. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995;267:1016-1018.
13. Peruzzi M, Wagtmann N, Long EO. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med 1996;184:1585-1590.
14. Zappacosta F, Borrego F, Brooks AG, Parker KC, Coligan JE. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci U S A 1997;94:6313-6318.
15. Rajagopalan S, Long EO. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 1997;185:1523-1528.
16. Mandelboim O, Wilson SB, Vales-Gomez M, Reyburn HT, Strominger JL. Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci U S A 1997;94:4604-4609.
17. Parker KC, Shields M, DiBrino M, Brooks A, Coligan JE. Peptide binding to MHC class I molecules: implications for antigenic peptide prediction. Immunol Res 1995;14:34-57.
18. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. HEPATOLOGY 2003;38:4-13.
19. Heller T, Sobao Y, Mizukoshi E, Rahman F, Sheets A, Gordon D, et al. HCV exposure in humans: Stimulation of cellular, but not humoral immune responses in the absence of detectable viremia [Abstract]. HEPATOLOGY 2003;38(Suppl 1):182A.
20. Norman PJ, Carrington CV, Byng M, Maxwell LD, Curran MD, Stephens HA, et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002;3:86-95.
21. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 1997;64:1017-1027.